Related Experiment Video
Updated: May 19, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
A case for combined ovarian and breast cancer prevention
1Breast Cancer Prevention Center, Division of Hematology and Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA. bpetroff@kumc.edu
Abstract:
Targeted prevention of ovarian cancer is hindered by the inaccessibility of ovarian tissue, lack of accepted biomarkers and low disease incidence. However, ovarian cancer has common risk factors and shared etiologies with breast cancer. Chemoprevention of ovarian cancer has been demonstrated incidentally during testing of novel breast cancer prevention drugs. Here it is hypothesized that the development of combined ovarian and breast cancer prevention strategies is a preferable strategy for ovarian cancer prevention.
Insights
Developing combined breast and ovarian cancer prevention strategies is proposed. This approach addresses challenges in ovarian cancer prevention, leveraging shared risk factors and incidental findings from breast cancer drug trials.
Area of Science:
- Oncology
- Cancer Prevention
- Epidemiology
Background:
- Ovarian cancer prevention is challenging due to limited tissue access, absent biomarkers, and low incidence.
- Ovarian and breast cancers share common risk factors and etiological pathways.
- Incidental chemoprevention of ovarian cancer has been observed during breast cancer drug development.
Purpose of the Study:
- To propose a combined strategy for ovarian and breast cancer prevention.
- To leverage shared risk factors for more effective cancer prevention.
- To explore novel approaches for ovarian cancer prevention.
Main Methods:
- Literature review on shared risk factors and etiologies of ovarian and breast cancers.
- Analysis of incidental findings from breast cancer chemoprevention trials.
- Hypothesis generation for combined prevention strategies.
Main Results:
- Ovarian and breast cancers exhibit significant overlap in risk factors and origins.
- Existing breast cancer prevention research offers potential avenues for ovarian cancer prevention.
- Combined strategies may overcome individual prevention challenges.
Conclusions:
- A combined approach to ovarian and breast cancer prevention is a viable and potentially superior strategy.
- Future research should focus on developing and testing integrated prevention methods.
- This integrated strategy could improve outcomes for both cancer types.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
